...
首页> 外文期刊>Cytotechnology >Cord blood serum harvesting by hydroxyethyl starch: a fetal bovine serum alternative in expansion of umbilical cord-derived mesenchymal stem cells
【24h】

Cord blood serum harvesting by hydroxyethyl starch: a fetal bovine serum alternative in expansion of umbilical cord-derived mesenchymal stem cells

机译:羟乙基淀粉收获脐带血血清:胎儿牛衍生间充质干细胞膨胀中的胎儿血清替代品

获取原文
   

获取外文期刊封面封底 >>

       

摘要

As a widely used cell culture supplement, fetal bovine serum (FBS) harbor high content of growth, proliferation, and adhesion factors. However, high cost, bio-safety, possible xenogeneic agent transmission, finite accessible, and ethical controversy are major obstacles that discourage the use of this additive. Accordingly, novel alternatives have been proposed with various pros and cons. Still, caution should be taken in choosing suitable substitute given that the alteration in the main aspects of cultured cells can be biased the consequences of clinical applications. Herein, the authors evaluated the impact of cord blood serum harvesting by hydroxyethyl starch (CBS-HES), as an enriched source of growth factors, on the basic mesenchymal stem cells (MSCs) characteristics. In the present experiment, umbilical cord-derived MSCs were isolated and continuously nourished with Dulbecco’s Modified Eagle Medium containing either 10, 15, and 20% CBS-HES or FBSs to compare their morphology, immunophenotype, growth and proliferation rate, death rate, cell cycle, and gene expression profiles. Although all enriched media supported the expansion of MSCs with comparable morphology, cell surface markers, death rate, c-MYC and p16 expression, and growth rate, CBS-HES treated cells significantly (P?
机译:作为一种广泛使用的细胞培养补充剂,胎儿牛血清(FBS)含有高含量的生长,增殖和粘附因子。然而,高成本,生物安全性,可能的异种剂转化,有限的可接近和道德争议是劝阻这种添加剂的主要障碍。因此,已经提出了具有各种优点和缺点的新型替代品。尽管如此,仍应考虑选择合适的替代品,因为培养细胞的主要方面的改变可以偏向临床应用的后果。在此,作者评估了羟乙基淀粉(CBS-HES)作为富含生长因子的富集源的脐带血血清的影响,基本间充质干细胞(MSCs)特征。在本实验中,脐带衍生的MSCs被分离并用含有10,15和20%CBS-HES或FBS的Dulbecco的改性鹰培养基连续营养,以比较它们的形态,免疫型,生长和增殖率,死亡率,细胞循环和基因表达谱。虽然所有富集的媒体都支持扩张MSCs,但具有相当的形态,细胞表面标记,死亡率,C-MYC和P16表达,以及生长速率,CBS-HES治疗细胞显着(p?<β05)表达了更多的HTERT基因浓度依赖的方式。然而,使用相同的添加剂浓度的添加剂,在培养细胞的细胞周期中没有观察到显着的转变,该发现通过Ki-67免疫染色进一步证实。 CBS-HES作为一种可用和价格合理的添加剂,似乎是培养,繁殖和随后的MSC的临床应用的最佳性,相对安全,并且有前途的FBS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号